Psoriasis trials recruiting in New Jersey

All Psoriasis trials nationally

Cities in New Jersey

Recruiting trials in New Jersey

• A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
  NCT06979453 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · New Jersey: Clifton, Robbinsville
• A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis
  NCT07471048 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Englewood
• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
  NCT06857942 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: East Windsor, Hoboken
• A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
  NCT07290036 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: West Long Branch
• An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
  NCT03392337 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: East Windsor
• Duobrii in Combination With Biologics
  NCT04119102 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: East Windsor
• Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
  NCT03827876 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: East Windsor
• ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
  NCT04347473 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: East Windsor
• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
  NCT07116967 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female) · New Jersey: Teaneck, Verona
• Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
  NCT02418442 · Phase: Not specified · Ages: Up to 21 Years · Sex: All (male and female) · New Jersey: Hackensack, Morristown, New Brunswick, West Orange
• Taltz in Combination With Enstilar for Psoriasis
  NCT04372277 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: East Windsor
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: New Brunswick